4//SEC Filing
INTEGRA LIFESCIENCES HOLDINGS CORP 4
Accession 0001209191-17-018270
$IARTCIK 0000917520operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:09 PM ET
Size
11.9 KB
Accession
0001209191-17-018270
Insider Transaction Report
Form 4
Murphy Raymond G.
Director
Transactions
- Sale
Common Stock
2017-03-02$43.01/sh−5,238$225,268→ 60,894 total - Exercise/Conversion
Common Stock
2017-03-02$10.74/sh+5,238$56,256→ 66,132 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-03-02−5,238→ 0 totalExercise: $10.74Exp: 2017-05-20→ Common Stock (5,238 underlying)
Footnotes (4)
- [F1]On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.
- [F2]The price shown above represents the weighted average price of the shares sold. The range of sale prices was $42.84 to $43.09.
- [F3]25% of the stock options vested every quarter from the grant date of 5/20/2009.
- [F4]This employee's stock option was previously reported as covering 7,829 shares of common stock at an exercise price of $21.48 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
Issuer
INTEGRA LIFESCIENCES HOLDINGS CORP
CIK 0000917520
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000917520
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:09 PM ET
- Size
- 11.9 KB